Abstract |
A series of adenosine derivatives substituted at the 1'-, 2'-, or 3'-position of the ribose ring with a methyl group was synthesized and evaluated for antitumor activity. From this study 3'-C-methyladenosine (3'-Me-Ado) emerged as the most active compound, showing activity against human myelogenous leukemia K562, multidrug resistant human leukemia K562IU, human promyelocytic leukemia HL-60, human colon carcinoma HT-29, and human breast carcinoma MCF-7 cell lines with IC(50) values ranging from 11 to 38 muM. Structure-activity relationship studies showed that the structure of 3'-Me-Ado is crucial for the activity. Substitution of a hydrogen atom of the N(6)-amino group with a small alkyl or cycloalkyl group, the introduction of a chlorine atom in the 2-position of the purine ring, or the moving of the methyl group from the 3'-position to other ribose positions brought about a decrease or loss of antitumor activity. The antiproliferative activity of 3'-Me-Ado appears to be related to its ability to deplete both intracellular purine and pyrimidine deoxynucleotides through ribonucleotide reductase inhibition.
|
Authors | Palmarisa Franchetti, Loredana Cappellacci, Michela Pasqualini, Riccardo Petrelli, Patrizia Vita, Hiremagalur N Jayaram, Zsuzsanna Horvath, Thomas Szekeres, Mario Grifantini |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 48
Issue 15
Pg. 4983-9
(Jul 28 2005)
ISSN: 0022-2623 [Print] United States |
PMID | 16033277
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 3'-C-methyladenosine
- Antineoplastic Agents
- Ribonucleotide Reductases
- Adenosine
|
Topics |
- Adenosine
(analogs & derivatives, chemical synthesis, chemistry, pharmacology)
- Antineoplastic Agents
(chemical synthesis, chemistry, pharmacology)
- Cell Line, Tumor
- Drug Screening Assays, Antitumor
- Humans
- Ribonucleotide Reductases
(antagonists & inhibitors)
- Structure-Activity Relationship
|